The role of multimodality imaging in diabetic cardiomyopathy: a brief review
2024

The Role of Multimodality Imaging in Diabetic Cardiomyopathy

publication Evidence: moderate

Author Information

Author(s): Adel Fadi W., Horng H. Chen

Primary Institution: Mayo Clinic, Rochester, MN, United States

Hypothesis

What is the role of multimodality imaging in the diagnosis and management of diabetic cardiomyopathy?

Conclusion

Multimodality imaging is crucial for diagnosing, staging, and managing diabetic cardiomyopathy, providing distinct insights into cardiac structure and function.

Supporting Evidence

  • Echocardiography is the gold standard for diagnosing diabetic cardiomyopathy due to its high resolution and accessibility.
  • Cardiac magnetic resonance imaging can assess myocardial fibrosis and altered metabolism, which are important in diabetic cardiomyopathy.
  • Nuclear imaging techniques like PET and gated SPECT reveal significant metabolic alterations in diabetic cardiomyopathy.

Takeaway

This study talks about how different types of heart imaging can help doctors understand and treat heart problems in people with diabetes.

Methodology

This is a mini review discussing the pathophysiology, staging, role of multimodality imaging, and therapeutics in diabetic cardiomyopathy.

Potential Biases

Potential bias in the selection of studies reviewed.

Limitations

The review does not provide original research data and relies on existing literature.

Digital Object Identifier (DOI)

10.3389/fendo.2024.1405031

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication